BioFab3D@ACMD recipient of MTPConnect funding

 

BioFab3D@ACMD is one of 14 national projects to receive funding over two years from MTPConnect - the Medical Technologies and Pharmaceuticals Industry Growth Centre. These projects could also leverage as much as $32 million in industry partner funds.

Funding is via MTPConnect’s Project Fund Program, a "competitive, minimum dollar-for-dollar matched funding program that aims to invest in big, bold ideas to boost the innovation, productivity and competitiveness of Australia’s MTP sector."

Sue MacLeman, CEO of MTPConnect, said, “The MTP sector has a fantastic opportunity for growth, but is currently hindered by constraints including a lack of collaboration between business and research, skills shortages, the need for more focused funding and investment, and the need for more streamlined and harmonised regulatory and market access frameworks. There also needs to be a focus on globally competitive incentives and long-term policy vision and stability. The selection panel has chosen these 14 projects because they creatively address many of these barriers and have the potential to have a major impact on the sector.”

MTPConnect’s Project Funds have been made available as part of the Australian Government’s $250 million Industry Growth Centres Initiative.

For a full list of successful applicants and to see the full media release, visit MTPConnect.